Similar islet function in islet allotransplant and autotransplant recipients, despite lower islet mass in autotransplants

Transplantation

Volumn 91, Issue 3, 2011, Pages 367-372

  Bellin, Melena D ^a   Sutherland, David E R ^a   Beilman, Gregory J ^a   Hong Mcatee, Irene ^b   Balamurugan, A N ^a   Hering, Bernhard J ^a   Moran, Antoinette ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Chronic pancreatitis; Islet allotransplant; Islet autotransplant; Type 1 diabetes mellitus

Indexed keywords

ARGININE; HEMOGLOBIN A1C; INSULIN;

ADULT; AGE; ARTICLE; AUTOGRAFT; AUTOTRANSPLANTATION; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE TOLERANCE; GRAFT RECIPIENT; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; MALE; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; SEX DIFFERENCE;

ADULT; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MIDDLE AGED; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 79951515824     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318203fd09     Document Type: Article

References (37)

1. Shapiro JAM, Lakey JRT, Paty BW, et al. Strategic opportunities in clinical islet transplantation. Transplantation 2005; 79: 1304.
2. Ryan EA, Paty BW, Senior PA, et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005; 54: 2060.
3. Alejandro R, Barton FB, Hering BJ, et al; Collaborative Islet Transplant Registry Investigators. 2008 Update from the collaborative islet transplant registry. Transplantation 2008; 86: 1783.
4. Huurman VA, Hilbrands R, Pinkse GG, et al. Cellular islet autoimmu-nity associates with clinical outcome of islet cell transplantation. PLoS One 2008; 3: e2435.
5. Hilbrands R, Huurman VA, Gillard P, et al. Differences in baseline lymphocyte counts and autoreactivity are associated with differences in outcomeofislet cell transplantationintype1diabetic patients.Diabetes 2009; 58: 2267.
6. Monti P, Scirpoli M,Maffi P,et al. Islet transplantation in patients with autoimmune diabetes induces homeostatic cytokines that expand au-toreactive memory T cells. J Clin Invest 2008; 118: 1806.
7. Roelen DL, Huurman VA, Hilbrands R, et al. Relevance of cytotoxic alloreactivity under different immunosuppressive regimens in clinical islet cell transplantation. Clin Exp Immunol 2009; 156: 141.
8. Nir T, Melton DA, Dor Y. Recovery from diabetes in mice by beta cell regeneration. J Clin Invest 2007; 117: 2553.
9. Noguchi H. Activation of c-Jun NH2-terminal kinase during islet isolation. Endocr J 2007; 54: 169.
10. Abdelli S, Ansite J, Roduit R, et al. Intracellular stress signaling pathways activated during human islet preparation and following acute cytokine exposure. Diabetes 2004; 53: 2815.
11. Chhabra P, Wang K, Zeng Q, et al. Adenosine A(2A) agonist administration improves islet transplant outcome: Evidence for the role of innate immunity in islet graft rejection. Cell Transplant 2010; 19: 597.
12. Lai Y, Chen C, Linn T. Innate immunity and heat shock response in islet transplantation. Clin Exp Immunol 2009; 157: 1.
13. Blondet JJ, Carlson AM, Kobayashi T, et al. The role of total pancrea-tectomy and islet autotransplantation for chronic pancreatitis. Surg Clin North Am 2007; 87: 1477.
14. Jie T, Hering BJ, Ansite JD, et al. Pancreatectomy and auto-islet transplant in patients with chronic pancreatitis. ACS 2005; 201(3 supp): S14.
15. Sutherland DE, Gruessner AC, Carlson AM, et al. Islet autotransplant outcomes after total pancreatectomy: A contrast to islet allograft outcomes. Transplantation 2008; 86: 1799.
16. Ahmad SA, Lowy AM, Wray CJ, et al. Factors associated with insulin and narcotic independence after islet autotransplantation in patients with severe chronic pancreatitis. J Am Coll Surg 2005; 201: 680.
17. Nielsen JH, Mandrup-Poulsen T, Nerup J. Direct effects of cyclosporin A on human pancreatic beta-cells. Diabetes 1986; 35: 1049.
18. RicordiC,Zeng YJ, Alejandro R, etal. Invivo effectof FK506onhuman pancreatic islets. Transplantation 1991; 52: 519.
19. Ishizuka J, Gugliuzza KK, Wassmuth Z, et al. Effects of FK506 and cyclosporine on dynamic insulin secretion from isolated dog pancreatic islets. Transplantation 1993; 56: 1486.
20. Pirsch JD, Miller J, Deierhoi MH, et al. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group. Transplantation 1997; 63: 977.
21. Cantaluppi V, Biancone L, Romanazzi GM, et al. Antiangiogenic and immunomodulatory effects of rapamycin on islet endothelium: Relevance for islet transplantation. Am J Transplant 2006; 6: 2601.
22. Contreras JL, Eckstein C, Smyth CA, et al. Brain death significantly reduces isolated pancreatic islet yields and functionality in vitro and in vivo after transplantation in rats. Diabetes 2003; 52: 2935.
23. Pileggi A, Ribeiro MM, Hogan AR, et al. Impact of pancreatic cold preservation on rat islet recovery and function. Transplantation 2009; 87: 1442.
24. Paraskevas S, Maysinger D, Wang R, et al. Cell loss in isolated human islets occurs by apoptosis. Pancreas 2000; 20: 270.
25. Davalli AM, Scaglia L, Zangen DH, et al. Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function. Diabetes 1996; 45: 1161.
26. Finzi G, Davalli A, Placidi C, et al. Morphological and ultrastructural features of human islet grafts performed in diabetic nude mice. Ultra-struct Pathol 2005; 29: 525.
27. Robertson RP, Lanz KJ, Sutherland DE,et al. Prevention of diabetes for up to 13 years by autoislet transplantation after pancreatectomy for chronic pancreatitis. Diabetes 2001; 50: 47.
28. Sutherland DE, RadosevichD,BlandB,etal. Total pancreatectomy and islet autotransplant for chronic pancreatitis: Early outcomes in recent cases [abstract]. Pancreas 2009; 38: 1051.
29. National Diabetes Information Clearinghouse. National Diabetes Statistics, 2007 [homepage on the Internet]. 2007 [cited September 12, 2010]. Available at: National Institutes of Health, NIDDK Web site: http://diabetes.niddk.nih.gov/dm/pubs/statistics/. Accessed September 12, 2010.
30. Shapiro AM, Ricordi C, Hering BJ, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006; 355: 1318.
31. Hering BJ, Kandaswamy R, Harmon JV, et al. Transplantation of cultured islets from two-layer preserved pancreases in type 1 diabetes with anti-CD3 antibody. Am J Transplant 2004; 4: 390.
32. Bellin MD, Kandaswamy R, Parkey J, et al. Prolonged insulin independence after islet allotransplants in recipients with type 1 diabetes. Am J Transplant 2008; 8: 2463.
33. Hering BJ, Kandaswamy R, Ansite JD, et al. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA 2005; 293: 830.
34. Anazawa T, Balamurugan AN, Bellin M, et al. Human islet isolation for autologous transplantation: Comparison of yield and function using SERVA/Nordmark vs. Roche enzymes. Am J Transplant 2009; 9: 2383.
35. Ricordi C,Lacy PE, Scharp DW. Automated islet isolation from human pancreas. Diabetes 1989; 38(suppl 1): 140.
36. Lake SP, Bassett PD, Larkins A, et al. Large-scale purification of human islets utilizing discontinuous albumin gradient on IBM 2991 cell separator. Diabetes 1989; 38(suppl 1): 143.
37. Meier JJ, Hong-McAtee I, Galasso R, et al. Intrahepatic transplanted islets in humans secrete insulin in a coordinate pulsatile manner directly into the liver. Diabetes 2006; 55: 2324.